
Solution structures of the fibronectin‐like Leishmania gp63 SRYD‐containing sequence in the free and antibody‐bound states
Author(s) -
Petit MarieChristine,
Orlewski Piotr,
Tsikaris Vassilios,
SakarellosDaitsiotis Maria,
Sakarellos Constantinos,
Tzinia Athina,
Konidou Georgia,
Soteriadou Ketty P.,
Marraud Michel,
Cung Manh Thong
Publication year - 1998
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1046/j.1432-1327.1998.2530184.x
Subject(s) - chemistry , fibronectin , stereochemistry , hydrogen bond , peptide , crystallography , sequence (biology) , biophysics , molecule , biochemistry , biology , cell , organic chemistry
The anti‐SRYD monoclonal antibody (mAbSRYD) raised against the IASRYDQL synthetic octapeptide, the 250−257 sequence of the Leishmania major surface glycoprotein gp63 recognizes both SRYD‐containing peptides and the whole cognate major surface protein on intact parasites. Two SRYD‐containing peptides, which antigenically and functionally mimic the RGDS sequence of fibronectin and efficiently inhibit parasite attachment to the macrophage receptors, were studied by two‐dimensional transferred nuclear Overhauser effect experiments in the presence of mAbSRYD. The antibody‐bound IASRYDQL octapeptide solution conformation was determined on the basis of 55 interproton‐distance restraints, derived from NMR measurements. Eighteen structures which were first generated using an approach combining distance geometry and molecular dynamics, converge by energy minimization toward a folded structure with an average rmsd from the experimental data of less than 0.05 nm for the overall backbone and 0.025 nm for the SRYD motif. A distorted γ‐turn was found, stabilized by the backbone−backbone D255‐NH to R253‐CO hydrogen bond, while the R253 and D255 side chains are pointing in opposite directions. This latter antibody‐bound structure is compared with that of the free octapeptide in dimethylsulfoxide solution, and with the crystal structure of the RYD fragment in OPG2 Fab, an antireceptor antibody that mimics the RGD cell adhesion site. On this basis, a mechanism for IASRYDQL−receptor interaction is discussed.